Search results for "Diseases."

showing 10 items of 20181 documents

Real-world experience with obeticholic acid in patients with primary biliary cholangitis

2021

Background & aims Obeticholic acid (OCA) is the second-line treatment approved for patients with primary biliary cholangitis (PBC) and an inadequate response or intolerance to ursodeoxycholic acid. We aimed to evaluate the effectiveness and safety of OCA under real-world conditions. Methods Patients were recruited into the Italian PBC Registry, a multicentre, observational cohort study that monitors patients with PBC at national level. The primary endpoint was the biochemical response according to Poise criteria; the secondary endpoint was the biochemical response according to normal range criteria, defined as normal levels of bilirubin, alkaline phosphatase (ALP), and alanine aminotransfer…

upper limit of normalCirrhosisALTAMAAutoimmunityantinuclear antibodiesULNPBCGastroenterologyUDCASettore MED/12ULN upper limit of normalobeticholic acidaRR adjusted risk ratio.CRFs case record formAST aspartate transferaseClinical endpointGGT gamma-glutamyl transferaseQCprimary biliary cholangitisGastroenterologyUrsodeoxycholic acidANATCCCirrhosisCholestasiTIPSTreatment Completer CohortANA antinuclear antibodiemedicine.medical_specialtyRRUDCA ursodeoxycholic acidTIPS transjugular intrahepatic portosystemic shuntOCACirrhosiALP alkaline phosphataseautoimmune hepatitismedicine.diseasedigestive system diseasesDiscontinuationKeywords: AIH autoimmune hepatitiQC quality controlchemistrygamma-glutamyl transferaserandomised controlled trialelectronic data captureantimitochondrial antibodiesaspartate transferaseAutoimmune hepatitischemistry.chemical_compoundAIHCRFsImmunology and Allergyadjusted risk ratioANA antinuclear antibodiesRR risk ratioOverall cohortALT alanine transferaseAMA antimitochondrial antibodieCholestasisCRFs case record formsObeticholic acidOverlap PBC-AIHursodeoxycholic acidOCA obeticholic acidTolerabilityalkaline phosphataseRCTResearch Articlemedicine.drugcase record formsContext (language use)AMA antimitochondrial antibodiesInternal medicineEDC electronic data capturetransjugular intrahepatic portosystemic shuntInternal MedicinemedicineRCT randomised controlled trialaRR adjusted risk ratioOClcsh:RC799-869quality controlalanine transferaseASTaRRHepatologybusiness.industryAutoimmunity; Cholestasis; Cirrhosis; Overlap PBC-AIHAIH autoimmune hepatitisTCC Treatment Completer CohortPBC primary biliary cholangitiGGTrisk ratioOC Overall cohortALPlcsh:Diseases of the digestive system. GastroenterologyPBC primary biliary cholangitisbusinessEDC
researchProduct

Incidencia, factores de riesgo y significado pronóstico de la proteinuria en el trasplante renal. Valor predictivo de la proteinuria precoz sobre la …

2010

La proteinuria es el principal marcador independiente de progresión de enfermedad renal en riñones nativos. En el trasplante renal es indicativa de lesión renal a nivel glomerular y tubulointersticial, y se ha relacionado con una peor supervivencia del injerto y del paciente. No obstante, existen pocas evidencias acerca del papel pronóstico y predictivo de la proteinuria en el trasplante renal, sobre todo en lo que respecta a la proteinuria precoz y de bajo grado. En este trabajo de investigación se ha intentado profundizar en el conocimiento de la proteinuria en nuestra población trasplantada renal que incluye una elevada prevalencia de trasplantes con órganos de donantes con criterios exp…

urogenital systemFacultat de Medicina617urologic and male genital diseasesCirurgia. Ortopèdia. Oftalmologiafemale genital diseases and pregnancy complications
researchProduct

Tema 12-AP especial

2020

Tema 12-Patologia renal inflamatòria glomerular

urogenital systemUNESCO::CIENCIAS MÉDICASurologic and male genital diseasesfemale genital diseases and pregnancy complications
researchProduct

Changes in the receptor profile of the lower urinary tract in the aging male

2004

Benign prostatic hyperplasia (BPH) is one of th e most common effects of aging in men. Epidemiologists estimate that about one quarter of all men over 50 years of age suffer from BPH-derived voiding symptoms. Future demographic developments, with higher relative shares of older people, will increase the socioeconomic impact of this disease. Polder et al. (1994) calculated for the Netherlands that the treatment costs of BPH will double by 2035. Office visits for BPH related symptoms increased in the USA from 1.4 million in 1990 to 6 million in 1995, reflecting the increased public awareness of the problem and the increased desire for treatment (Kaplan et al. 1996).

urogenital systembusiness.industryAging maleUrinary systemDiseaseHyperplasiaurologic and male genital diseasesQuarter (United States coin)medicine.diseaseBladder outlet obstructionmedicinebusinessOlder peopleSocioeconomic statusDemography
researchProduct

MOESM4 of Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study

2017

Additional file 4. Characteristics of bladder cancer patients by hospitals.

urologic and male genital diseasesfemale genital diseases and pregnancy complications
researchProduct

MOESM3 of Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study

2017

Additional file 3. Diagnostic tests for bladder cancer patients.

urologic and male genital diseasesfemale genital diseases and pregnancy complications
researchProduct

Additional file 2: of Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

2018

Table S2. Baseline clinical characteristics of patients grouped by eGFR and albuminuria. (DOCX 19 kb)

urologic and male genital diseasesfemale genital diseases and pregnancy complications
researchProduct

The Role of Existential Concerns in the Individual’s Decisions regarding COVID-19 Vaccine Uptake: A Survey among Non-Vaccinated Italian Adults during…

2022

Recent studies have suggested that health constructs embraced by the Terror Management Theory (TMT) and the Basic Psychological Needs Theory (BPNT) may drive individuals’ COVID-19 health-related decisions. This study examines the relationships between existential concerns (ECs; within the TMT), basic psychological needs (BPNs; within the BPNT) and COVID-19 vaccine hesitancy (VH), as well as the mediating role of negative attitudes toward COVID-19 vaccines. A cross-sectional survey was carried out from April to May 2021 on a sample of two hundred and eighty-seven adults (Mage = 36.04 ± 12.07; 59.9% females). Participants provided information regarding existential concerns, basic psychologica…

vaccine hesitancy; existential concerns; basic psychological needs; attitudes; COVID-19; Pfizer-BioNTech vaccine; AstraZeneca vaccinePharmacologyattitudesInfectious Diseasesexistential concernsDrug DiscoveryImmunologybasic psychological needsCOVID-19vaccine hesitancyPharmacology (medical)AstraZeneca vaccinePfizer-BioNTech vaccineVaccines
researchProduct

Vacunas y evolución: ¿Por qué es importante entender la diversidad genética de los patógenos?

2013

Desde el punto de vista de las intervenciones en salud pública no hay mejor arma que aquella que permite prevenir la transmisión o aparición de la enfermedad. Dentro del campo de las enfermedades infecciosas las vacunas se han convertido en esa arma y han permitido controlar muchas de ellas. Hoy en día hay un gran número de enfermedades infecciosas emergentes para las que no existen vacunas o enfermedades olvidadas que están reemergiendo. Nuevas vacunas se están desarrollando para atacar a los patógenos que están relacionados con ellas. Sin embargo, y a pesar de la importancia del diseño de una buena vacuna, la diversidad genética de los patógenos no se ha tenido siempre en cuenta. El estud…

variación antigénicabiología; evoluciónvariació antigènica; tuberculosi; grip; sistema immune; malalties infecciosesevoluciónantigenic variationinfectious diseasesvariación antigénica; tuberculosis; gripe; sistema inmune; enfermedades infecciosassistema inmunebiologia; evolucióevolutionvariació antigènicagriptuberculosiantigenic variation; tuberculosis; flu; immune system; infectious diseasesbiology; evolutionflubiologygripemalalties infecciosesimmune systemtuberculosisevolucióenfermedades infecciosasbiologíasistema immunebiologia
researchProduct

Associations of Sex Hormones and Hormonal Status With Arterial Stiffness in a Female Sample From Reproductive Years to Menopause

2021

ObjectiveLoss of sex hormones has been suggested to underlie menopause-associated increment in cardiovascular risk. We investigated associations of sex hormones with arterial stiffness in 19–58-years-old women. We also studied associations of specific hormonal stages, including natural menstrual cycle, cycle with combined oral contraceptives (COC) and menopausal status with or without hormone therapy (HT), with arterial stiffness.MethodsThis study includes repeated measurements of 65 healthy women representing reproductive (n=16 natural, n=10 COC-users) and menopause (n=5 perimenopausal, n=26 postmenopausal, n=8 HT-users) stages. Arterial stiffness outcomes were aortic pulse wave velocity (…

vascular aginghormonal contraceptionvascular stiffnesspulse wave analysismenstruationRC648-665reproductive hormonesDiseases of the endocrine glands. Clinical endocrinologyFrontiers in Endocrinology
researchProduct